VATHLT8250 - The zero rate for free-of-charge medicines: Free-of-charge medicines for use in NHS treatment: Regulation 167 of the Human Medicines Regulations 2012
Medicinal products without a marketing authorisation (unlicensed medicines) can be supplied in the UK under regulation 167 of the Human Medicines Regulations 2012.
Medicinal products with a marketing authorisation can be supplied for a different indication than that for which they have the marketing authorisation. This will be ‘off-label use’, and will also come under regulation 167 of the Human Medicines Regulations 2012.
Medicinal products supplied for no consideration in accordance with regulation 167 of the Human Medicines Regulations 2012 will be an ‘authorised supply’ for the purpose of items 1ZB and 1ZC, and will qualify for the zero rate provided all other conditions are met.
Pharmaceutical companies supplying unlicensed or off-label medicines may refer to the terms ‘named patient basis’, ‘compassionate use’, or ‘specials’. Unlicensed medicines or medicines supplied for off-label use will sometimes be supplied for a consideration, in which case they will not qualify for zero-rating under items 1ZB or 1ZC.
Unlicensed medicines can also be supplied for use in the Early Access to Medicines Scheme – see VATHLT8260.